Ascent Resources PLC Issue of Equity & Total Voting Rights

RNS Number : 0187V

Ascent Resources PLC

28 January 2025

 

28 January 2025

 

Ascent Resources plc

("Ascent" or the "Company")

Issue of Equity & Total Voting Rights

Ascent Resources Plc (LON: AST) announces today that it has agreed to issue 1,149,058 new ordinary shares of 0.5 pence each in the Company ("New Ordinary Shares") at an issue price of 2.3 pence.

279,493 shares have been issued to a former Director for services provided whilst they were employed in October and November 2024 and 869,565 shares have been issued to Optimo Research in relation to services to be provided over the next year.

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will occur at 8:00 on 31 January 2025. The New Ordinary Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after Admission and will otherwise be identical to and rank on Admission pari passu in all respects with the existing Ordinary Shares.

Following Admission of the New Shares the Company will have 308,652,323 Ordinary Shares in issue, none of which will be held in treasury. Accordingly, the total number of voting rights in the Company will be 307,503,265 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Ascent Resources plc Andrew Dennan	Via Vigo Communications
Zeus Capital, Nominated Adviser & Broker James Joyce / James Bavister	0203 829 5000
Novum Securities, Joint Broker John Belliss / Colin Rowbury	0207 399 9400

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEPPUPPGUPAGMR